ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
37.86
-0.62 (-1.61%)
May 20, 2026, 11:54 AM CST
Market Cap17.28B -0.5%
Revenue (ttm)940.78M -21.9%
Net Income199.99M
EPS0.44
Shares Out449.03M
PE Ratio86.40
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,369,657
Average Volume19,436,372
Open40.49
Previous Close38.48
Day's Range37.60 - 40.49
52-Week Range29.31 - 81.48
Beta0.53
RSI49.46
Earnings DateApr 24, 2026

About SHE:300723

ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in... [Read more]

Sector Healthcare
Founded 2002
Employees 1,294
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements